Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Young researchers shine during Afromontane Colloquium

2016-12-01

From the left are Drs Reetu Sogani (India),
Greg Greenwood (US-Switzerland), Teboho Manchu
(Acting Campus Principal), Drs Jianchu Xu (China),
Henri Rueff (Switzerland), Glen Taylor (Senior Director:
Research Development), and Elsa Crause
(Campus Vice-Principal: Academic and Research).

The University of the Free State’s Afromontane Research Unit (ARU), which is situated on the Qwaqwa Campus, has the potential to produce some of the world’s best and dynamic young researchers. This is the view of Dr Henri Rueff, who was one of the keynote speakers during the recent ARU Colloquium hosted at Golden Gate in the Eastern Free State.

Dr Rueff, a geographer and environmental economist from the Universities of Basel and Bern in Switzerland, was referring to no less than ten Qwaqwa Campus postgraduate students who made oral and poster presentations during the inaugural international colloquium.

“You have some of the world’s most motivated and highly skilled students who have the courage to stand in front of extremely critical scientists from all over the globe – and that must be commended,” he said.

Also talking about the students at the colloquium, was Dr Reetu Sogani from India, who said that her first trip to South Africa did not disappoint. “This colloquium was a very good learning experience for me as I had the opportunity to interact with brilliant and young scientists from this part of the world,” she added. In closing the colloquium, the Senior Director: Research Development, Dr Glen Taylor, committed the UFS to the success of the unit.

“The ARU will strengthen the research output of the campus. But most critically, it is setting the research agenda for the Qwaqwa Campus, and for the institution at large, to address the challenges that the surrounding mountain communities are faced with,” he said.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept